Dr. Robert Hariri
Dr. Robert J. Hariri is the founder and Chief Executive Officer of Celularity Inc., a privately held company developing novel cellular and regenerative therapeutics around the human placenta. Celularity’s technology platform is the product of over two decades of innovation and discovery by Dr. Hariri to unlock the human placenta’s regenerative potential to amplify the body’s ability to fight disease, heal and regenerate itself, and extend the healthy human lifespan.
Dr. Hariri served as Chairman and Chief Scientific Officer of Celgene Cellular Therapeutics, a division of Celgene Corporation [NASDAQ: CELG] from 2002 to 2014. He was founder, Chairman and Chief Scientific Officer at Anthrogenesis Corporation/LIFEBANK, Inc., a privately held human stem cell therapeutics company, which Celgene Corporation acquired in 2002.
In 2013, Dr. Hariri co-founded Human Longevity, Inc., a privately-held genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span. He also co-founded and served as Vice Chairman and Chief Scientific Officer of Neurodynamics, a privately held medical device and technology corporation. Dr. Hariri is an adjunct associate professor of pathology at the Mount Sinai School of Medicine and has held key academic positions at Weill Medical College of Cornell University and the Cornell University Graduate School of Medical Science, including serving as the Director of the Center for Trauma Research.
Dr. Hariri is a Director of Cryoport, Inc. [NASDAQ: CYRX], Bionik Laboratories Corp. [OTCQX: BNKL], Provista Diagnostics, and Rocket Racing, Inc. He is a member of the scientific advisory board for the Archon X Prize for Genomics, which is awarded by the X Prize Foundation. Dr. Hariri also serves as a trustee of the J. Craig Venter Institute; a trustee of the Liberty Science Center; and a commissioner of the New Jersey Commission for Cancer Research. He has received numerous honors for his contributions to biomedicine and aviation. He has served as a member of the board of visitors at Columbia University School of Engineering & Applied Sciences, and the Science & Technology Council of the College of Physicians and Surgeons.
Dr. Hariri received his undergraduate degree from Columbia University School of Engineering and Applied Sciences, and was awarded his M.D. and Ph.D. degrees from Cornell University Medical College. He received his surgical training at The New York Hospital-Cornell Medical Center, where he directed the Aitken Neurosurgery Laboratory and the Center for Trauma Research.
Site: http://www.humanlongevity.com/about/robert-hariri/
Facebook: https://www.facebook.com/Celgene/
Twitter: https://twitter.com/HaririRobert